Market Analysis

The global sialic acid market share is predicted to touch USD 15,225.3 thousand at a 12.19% CAGR over the forecast period (2017-2024), states the latest Market Research Future (MRFR) report. Sialic acid is the generic term for neuraminic acid derivatives. This can be naturally produced from plants such as salix and willow tree or synthetically produced from carbon dioxide and sodium phenolate. Based on its anti-microbial, comedolytic, keratolytic, anti-inflammatory, and fungicidal properties, sialic acid has an extensive range of applications in the pharmaceutical, healthcare, and cosmetics industry. It is widely used for making cosmetics owing to the fact that this aids in moisturizing as well as dissolving the substance, which makes the layers of the skin to stick together.

Various factors are propelling the sialic acid market growth. Some of these factors, according to the Market Research Future report, include growing demand in cosmetic skincare, and haircare products due to increasing consumer awareness about its benefits, and extensive use in the manufacturing of aspirin. Rising consumption of aspirin tablets due to its excellent pain-relieving action, and easy availability of the drug is also boosting the market growth. Additional factors pushing market growth include increasing use in infant milk formula, improved lifestyles, upgraded purchasing power amongst women, changes in food consumption patterns, and growing awareness about cosmetic products.

On the contrary, growing concerns about the side effects of taking aspirin may impede the sialic acid market growth over the forecast period.

Key Players

Leading players profiled in the sialic acid market report include Wuhan Zhongke Optics Valley Green Biotechnology Co., Ltd (China), Jennewein Biotechnologie GmbH (Germany), Carbosynth Limited (UK), Rose Scientific Inc. (US), RS Pharmchem Co., Ltd (China), Nacalai Tesque (Japan), and Inbiose NV (Belgium), among others. Key players have adopted several strategies to create a niche in the market such as partnerships, mergers and acquisitions, collaborations, expansions, product innovation and launches, and research and development.

Market Segmentation

The MRFR report offers a wide segmental analysis of the sialic acid market on the basis of application and form.

Based on form, the sialic acid market is segmented into liquid and solid. Of these, the solid segment will have the largest share in the market during the forecast period. This segment is anticipated to grow at a 12.27% CAGR. Solid sialic acid is also known as dehydrated or dry sialic acid and includes crystallized and powered acid. It is widely used in the pharmaceutical and food industries due to its excellent blending capacity with other ingredients as well as high shelf life over the liquid form.

Based on application, the sialic acid market is segmented into personal care products, cosmetics, dietary supplements, infant nutrition, and others. Of these, the infant nutrition segment will dominate the market over the forecast period.

To get more info: https://www.marketresearchfuture.com/press-release/sialic-acid-market

Regional Analysis

By region, the sialic acid market report covers the latest trends and growth opportunities across North America, Europe, the Asia Pacific, and the Rest of the World. Of these, North America will command the market over the forecast period. This is on account of the presence of key manufacturers using advance equipment for extraction as well as purification of sialic acid coupled with easy accessibility of different sources of sialic acid including ovine milk, bovine, and porcine.

The sialic acid market in Europe is predicted to have the second-largest share in the market over the forecast period. This is owing to the growing consumer demand for infant milk formula and dietary supplements.

The sialic acid market in the APAC region is predicted to grow at the fastest pace over the forecast period. It is predicted to grow at a 12.64% CAGR.

Industry News

January 2019: Researchers at Imperial College London and LSTM have designed drugs that can help in combating any prospective new flu pandemic. It will target the cell receptors through which the virus enters the body. The antibody Fc fragments contain sialic acid, which will target both HA (haemagglutinin) and NA (neuraminidase), binding influenza viruses, thereby blocking their contact with human cells.